Insider Transactions in Q4 2022 at Albireo Pharma, Inc. (ALBO)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 27
2022
|
Pamela Stephenson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
469
-1.03%
|
$8,911
$19.06 P/Share
|
|
Dec 19
2022
|
Paul Streck Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
63,966
+50.0%
|
-
|
|
Dec 01
2022
|
Craig C. Hopkinson Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,495
+50.0%
|
-
|
|
Oct 24
2022
|
Ronald Harold Wilfred Cooper President and CEO |
SELL
Open market or private sale
|
Direct |
919
-1.63%
|
$17,461
$19.58 P/Share
|
|
Oct 24
2022
|
Martha J. Carter Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
104
-0.66%
|
$1,976
$19.58 P/Share
|
|
Oct 24
2022
|
Simon N.R. Harford CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
104
-0.31%
|
$1,976
$19.58 P/Share
|
|
Oct 24
2022
|
Michelle Graham Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
104
-0.39%
|
$1,976
$19.58 P/Share
|
|
Oct 24
2022
|
Jan Mattsson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
202
-0.35%
|
$3,838
$19.58 P/Share
|
|
Oct 24
2022
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
656
-1.42%
|
$12,464
$19.51 P/Share
|
|
Oct 24
2022
|
Pamela Stephenson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
104
-0.23%
|
$1,976
$19.58 P/Share
|
|
Oct 13
2022
|
Perceptive Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
179,132
-4.23%
|
$3,940,904
$22.4 P/Share
|
|
Oct 12
2022
|
Perceptive Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
97,219
-2.2%
|
$2,138,818
$22.75 P/Share
|
|
Oct 11
2022
|
Simon N.R. Harford CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
80
-0.24%
|
$1,840
$23.79 P/Share
|
|
Oct 11
2022
|
Perceptive Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
144,065
-2.06%
|
$3,457,560
$24.06 P/Share
|